MedicAlert Foundation, SCDAA And Fulcrum Therapeutics Partner To Help Streamline And Expedite ED Care For People Living With Sickle Cell Disease Through Rapid Access To Patient-Specific Care Plans - Fulcrum Therapeutics (NASDAQ:FULC)
Published on March 19, 2026.
The MedicAlert Foundation, SCDAA and Fulcrum Therapeutics are partnering to streamline and improve ED care for those with Sickle Cell Disease. The partnership is part of a larger effort to address the issue of the disease itself. The article also mentions the potential impact of this partnership.
Read Original Article